Bayesian Capital Management’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-4,773
Closed -$362K 848
2025
Q2
$362K Buy
+4,773
New +$338K 0.06% 351

Other funds holding SOLV

Bayesian Capital Management's SOLV Position: Q3 2025 in Review

Bayesian Capital Management sold out of Solventum (SOLV) in Q3 2025, closing a stake of 4,773 shares — an estimated $362K sold.

Bayesian Capital Management first reported a position in SOLV in Q2 2025 and held it in 1 quarter. The position peaked at $362K in Q2 2025. 868 funds tracked by Wall St. Rank hold SOLV as of Q3 2025.

  • Bayesian Capital Management reported no remaining Solventum position as of Q3 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 4,773 Solventum shares in Q3 2025, an estimated $362K.
  • Bayesian Capital Management first reported a position in Solventum in Q2 2025 and held it in 1 quarter.
  • Bayesian Capital Management's Solventum position peaked at $362K in Q2 2025.
  • 868 funds tracked by Wall St. Rank held Solventum as of Q3 2025.

Based on Bayesian Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.